文献速递妇科

人乳头瘤病毒病毒载量作为非16/18型高危人乳头瘤病毒阳性女性分诊工具:一项前瞻性筛查队列研究

Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
PubMed 文献 · Gynecol Oncol · 2017-11-21

该前瞻性筛查队列纳入1742名中国女性,随访十年,比较病毒载量、细胞学和醋酸视觉检查(VIA)对特定型别高危人乳头瘤病毒(hrHPV)阳性女性的分诊效果。结果显示HPV16/18阳性女性即使细胞学正常,CIN2+十年累积发生率仍高;非16/18型hrHPV阳性女性的CIN2+风险可被病毒载量分层,但VIA不能分层。作者认为在细胞学不可及的资源有限地区,可用病毒载量对非16/18型hrHPV阳性女性进行分诊。

要点

  • HPV16/18阳性女性即使细胞学正常,CIN2+十年累积发生率为15.3%。
  • 非16/18型hrHPV阳性女性中,病毒载量阈值10 RLU/CO可分层CIN2+风险(5.1% vs 27.2%)。
  • VIA不能分层非16/18型hrHPV阳性女性的CIN2+风险(19.1% vs 19.0%)。

核心结论

  • 研究结果支持指南将所有HPV16/18阳性女性转诊阴道镜,并建议在细胞学筛查不可及的资源有限地区使用病毒载量对非16/18型hrHPV阳性女性进行分诊。

研究设计与样本

  • 前瞻性筛查队列研究,纳入1742名中国女性,采用细胞学、醋酸视觉检查(VIA)和杂交捕获2代(HC2)检测进行筛查,随访十年。
  • 所有HC2阳性样本进行基因分型,病毒载量以HC2相对光单位/ cutoff(RLU/CO)测量。
  • 采用Kaplan-Meier法估计特定型别hrHPV病毒载量对应的宫颈上皮内瘤变2级及以上(CIN2+)十年累积发生率(CIR)。

主要发现

  • 基线hrHPV病毒载量按特定基因型分层与现患细胞学病变呈正相关。
  • HPV16/18阳性女性中,CIN2+十年CIR在细胞学正常者为15.3%,VIA正常者为32.4%,病毒载量RLU/CO<10者为23.6%,RLU/CO<100者为33.8%。
  • 非16/18型hrHPV阳性女性中,CIN2+十年CIR按细胞学分级为未明确意义的非典型鳞状细胞及以上(2.0% vs 34.6%)、病毒载量阈值10 RLU/CO(5.1% vs 27.2%)、100 RLU/CO(11.0% vs 35.5%)均有显著分层,但VIA不能分层(19.1% vs 19.0%)。

临床怎么用

  • 作者认为,所有HPV16/18阳性女性应转诊阴道镜。
  • 作者建议,在细胞学筛查不可及的资源有限地区,可使用病毒载量对非16/18型hrHPV阳性女性进行分诊。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: ASCCP cervical cancer screening guidelines recommend triaging high-risk human papillomavirus (hrHPV) positive women with cytology and genotyping, but cytology is often unavailable in resource-limited areas. We compared the long-term risk of cervical cancer and precancers among type-specific hrHPV-positive women triaged by viral load to cytology and visual inspection with acetic acid (VIA). METHODS: A cohort of 1742 Chinese women was screened with cytology, VIA, and Hybrid Capture 2 (HC2) test and followed for ten years. All HC2-positive samples were genotyped. Viral load was measured by HC2 relative light units/cutoff (RLU/CO). Ten-year cumulative incidence rate (CIR) of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) for type-specific hrHPV viral load was estimated using Kaplan-Meier methods. RESULTS: Baseline hrHPV viral load stratified by specific genotypes was positively correlated with prevalent cytological lesions. Ten-year CIR of CIN2+ was associated with cytological lesions and viral load. Among HPV 16/18-positive women, ten-year CIR of CIN2+ was high, even with normal cytology (15.3%), normal VIA (32.4%), viral load with RLU/CO<10 (23.6%) or RLU/CO<100 (33.8%). Among non-16/18 hrHPV positive women, ten-year CIR of CIN2+ was significantly stratified by cytology grade of atypical squamous cell of undetermined significance or higher (2.0% VS. 34.6%), viral load cutoffs at 10 RLU/CO (5.1% VS. 27.2%), at 100 RLU/CO (11.0% VS. 35.5%), but not by VIA (19.1% VS. 19.0%). CONCLUSIONS: Our findings support the guidelines in referring all HPV16/18 positive women to colposcopy and suggest triaging non-16/18 hrHPV positive women using viral loads in resource-limited areas where cytology screening was inaccessible.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Dong L, Wang MZ, Zhao XL, et al. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study. Gynecol Oncol. 2017. PMID: 29169614. doi:10.1016/j.ygyno.2017.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。